It's on the back of a new HPRA report that recommends controlled access to cannabis, which will be confined to the treatment of specified conditions.
Multiple sclerosis, epilepsy patients and those going through cancer treatment will be among those who can avail of the programme.
Minister Harris says this trial scheme is necessary for patients who are suffering from these conditions:
